188 related articles for article (PubMed ID: 20135267)
1. Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Gupta R; Thabah MM; Vaidya B; Gupta S; Lodha R; Kabra SK
Indian J Pediatr; 2010 Jan; 77(1):41-4. PubMed ID: 20135267
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
[TBL] [Abstract][Full Text] [Related]
3. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
van Rossum M; van Soesbergen R; de Kort S; ten Cate R; Zwinderman AH; de Jong B; Dijkmans B; van Venrooij WJ
J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
Brunner J; Sitzmann FC
Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
[TBL] [Abstract][Full Text] [Related]
5. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
7. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
8. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.
Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM
Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183
[TBL] [Abstract][Full Text] [Related]
9. Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial).
Omar A; Abo-Elyoun I; Hussein H; Nabih M; Atwa H; Gad S; Emad Y
Joint Bone Spine; 2013 Jan; 80(1):38-43. PubMed ID: 22575064
[TBL] [Abstract][Full Text] [Related]
10. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
Lipinska J; Lipinska S; Kasielski M; Smolewska E
Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Avcin T; Cimaz R; Falcini F; Zulian F; Martini G; Simonini G; Porenta-Besic V; Cecchini G; Borghi MO; Meroni PL
Ann Rheum Dis; 2002 Jul; 61(7):608-11. PubMed ID: 12079901
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.
Kuna AT; Lamot L; Miler M; Harjacek M; Simundic AM; Vrkic N
Clin Chem Lab Med; 2009; 47(12):1525-30. PubMed ID: 19842993
[TBL] [Abstract][Full Text] [Related]
13. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Habib HM; Mosaad YM; Youssef HM
Immunol Invest; 2008; 37(8):849-57. PubMed ID: 18991100
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
15. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Brunner JK; Sitzmann FC
Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999
[TBL] [Abstract][Full Text] [Related]
16. [Antibodies to mutated citrullinated vimentin and some associated autoantibodies in juvenile idiopathic arthritis].
Zhang L; Ru J; Jie X; Che G; Jin X; Li X
Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):948-51. PubMed ID: 26887552
[TBL] [Abstract][Full Text] [Related]
17. Limitations in the classification of childhood-onset rheumatoid arthritis.
Ferrell EG; Ponder LA; Minor LS; Angeles-Han ST; Kennedy CW; Rouster-Stevens KA; Rohani-Pichavant M; Vogler LB; Prahalad S
J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
Kasapçopur O; Altun S; Aslan M; Karaarslan S; Kamburoglu-Göksel A; Saribas S; Arisoy N; Kocazeybek B
Ann Rheum Dis; 2004 Dec; 63(12):1687-9. PubMed ID: 15547097
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
Hromadnikova I; Stechova K; Pavla V; Hridelova D; Houbova B; Voslarova S; Nekvasilova H; Vavrinec J
Autoimmunity; 2002 Sep; 35(6):397-401. PubMed ID: 12568120
[TBL] [Abstract][Full Text] [Related]
20. Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis.
Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
Pediatr Rheumatol Online J; 2011 Mar; 9():8. PubMed ID: 21439056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
